|
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2713-2719.
Prepublished online as a Blood First Edition Paper on November 22, 2005; DOI 10.1182/blood-2005-07-2990.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IIb 3 biogenesis is controlled by engagement of IIb in the calnexin cycle via the N15-linked glycan
W. Beau Mitchell,
JiHong Li,
Deborah L. French, and
Barry S. Coller
From Mount Sinai School of Medicine; and the Laboratory for Blood and Vascular Biology, Rockefeller University, New York, NY.
Although much is known about IIb 3 structure and function, relatively little is understood about its biogenesis. Thus, we studied the kinetics of pro- IIb production and degradation, focusing on whether proteasomal degradation or the calnexin cycle participates in these processes. In pulse-chase analyses, the time to half-disappearance of pro- IIb (t1/2) was the same in (1) HEK293 cells transfected with (a) IIb plus 3, (b) IIb alone, (c) mutant V298F IIb plus 3, or (d) I374T IIb plus 3; and (2) murine wild-type and 3-null megakaryocytes. Inhibition of the proteasome prolonged the t1/2 values in both HEK293 cells and murine megakaryocytes. Calnexin coprecipitated with IIb from HEK293 cells transfected with IIb alone, IIb plus 3, and V298F IIb plus 3. For proteins in the calnexin cycle, removal of the terminal mannose residue of the middle branch of the core N-linked glycan results in degradation. Inhibition of the enzyme that removes this mannose residue prevented pro- IIb degradation in 3-null murine megakaryocytes. IIb contains a conserved glycosylation consensus sequence at N15, and an N15Q mutation prevented pro- IIb maturation, complex formation, and degradation. Our findings suggest that pro- IIb engages the calnexin cycle via the N15 glycan and that failure of pro- IIb to complex normally with 3 results in proteasomal degradation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Beau Mitchell, J. Li, M. Murcia, N. Valentin, P. J. Newman, and B. S. Coller
Mapping early conformational changes in {alpha}IIb and {beta}3 during biogenesis reveals a potential mechanism for {alpha}IIb{beta}3 adopting its bent conformation
Blood,
May 1, 2007;
109(9):
3725 - 3732.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|